Trial Profile
A Phase IIa Open-label, Randomized Study to Compare the Safety, Tolerability and Pharmacokinetics (PK) of NM-IL-12 (rHuIL-12) to Standard of Care in Subjects With Open Surgical Wounds Following Colostomy Takedown
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Jul 2019
Price :
$35
*
At a glance
- Drugs NMIL 12 1 (Primary)
- Indications Surgical wound infections
- Focus Adverse reactions
- Sponsors Neumedicines
- 14 Nov 2018 Status changed from recruiting to completed.
- 29 Dec 2015 According to ClinicalTrials.gov record, status changed from not yet recruiting to recruiting.
- 09 Mar 2015 New trial record